Anavex’s slow journey to failure
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Hello, everyone, and welcome back. Damian here with a look at the year ahead for biotech, plus a long-awaited admission and a remembrance for one of medicine’s true stalwarts.
